Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. ARS Pharmaceuticals Inc shares valued at $140,000 were purchased by ERIC KARAS on Mar 20 ’25. At $14.00 per share, ERIC KARAS acquired 10,000 shares.
Also, Shawver Laura sold 49,600 shares, netting a total of over 556,046 in proceeds. Following the sale of shares at $11.21 each, the insider now holds 210,346 shares.
Before that, Shawver Laura had sold 400 shares from its account. In a trade valued at $4,400, the Director traded ARS Pharmaceuticals Inc shares for $11.00 each. Upon closing the transaction, the insider’s holdings decreased to 400 shares, worth approximately $3.01 million.
As published in their initiating research note from Scotiabank on March 07, 2025, ARS Pharmaceuticals Inc [SPRY] has been a Sector outperform and the price target has been revised to $30. Analysts at Oppenheimer started covering the stock with ‘”an Outperform”‘ outlook in a report released in early February. As of August 20, 2024, Cantor Fitzgerald has initiated its “an Overweight” rating for SPRY. Earlier on August 13, 2024, Raymond James upgraded its rating. Their new recommendation was “a Strong buy” for SPRY stock which previously was a “an Outperform”.
Analyzing SPRY Stock Performance
During the last five days, there has been a surge of approximately 19.75%. Over the course of the year, ARS Pharmaceuticals Inc shares have jumped approximately 35.64%. Shares of the company reached a 52-week high of $15.19 on 01/27/25 and a 52-week low of $10.00 on 03/04/25. A 50-day SMA is recorded $12.00, while a 200-day SMA reached $12.27.
Support And Resistance Levels for ARS Pharmaceuticals Inc (SPRY)
According to the 24-hour chart, there is a support level at 12.70, which, if violated, would cause prices to drop to 11.09. In the upper region, resistance lies at 15.50. The next price resistance is at 16.70. RSI (Relative Strength Index) is 71.92 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.02, which suggests the price will increase in the coming days. Percent R is at 15.27%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
